"Cholangitis, Sclerosing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS.
| Descriptor ID |
D015209
|
| MeSH Number(s) |
C06.130.120.200.110
|
| Concept/Terms |
Cholangitis, Sclerosing- Cholangitis, Sclerosing
- Cholangitides, Sclerosing
- Sclerosing Cholangitides
- Sclerosing Cholangitis
- Cholangiitis, Sclerosing
- Cholangiitides, Sclerosing
- Sclerosing Cholangiitides
- Sclerosing Cholangiitis
Primary Sclerosing Cholangitis- Primary Sclerosing Cholangitis
- Cholangitides, Primary Sclerosing
- Primary Sclerosing Cholangitides
- Sclerosing Cholangitides, Primary
- Sclerosing Cholangitis, Primary
- Cholangitis, Primary Sclerosing
|
Below are MeSH descriptors whose meaning is more general than "Cholangitis, Sclerosing".
Below are MeSH descriptors whose meaning is more specific than "Cholangitis, Sclerosing".
This graph shows the total number of publications written about "Cholangitis, Sclerosing" by people in this website by year, and whether "Cholangitis, Sclerosing" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 1 | 3 |
| 2017 | 1 | 0 | 1 |
| 2018 | 3 | 0 | 3 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholangitis, Sclerosing" by people in Profiles.
-
Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease. Gastroenterology. 2024 Jul; 167(2):315-332.
-
Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis. Nat Med. 2023 Jun; 29(6):1520-1529.
-
The Role of the Intestine in the Pathogenesis of Primary Sclerosing Cholangitis: Evidence and Therapeutic Implications. Hepatology. 2020 09; 72(3):1127-1138.
-
IgG4 related autoimmune pancreatitis and sclerosing cholangitis. Turk J Gastroenterol. 2019 03; 30(3):303-304.
-
Autoimmune Liver Diseases in Children. Pediatr Ann. 2018 Nov 01; 47(11):e452-e457.
-
Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease-Authors' reply. Aliment Pharmacol Ther. 2018 05; 47(10):1423-1424.
-
Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease. Aliment Pharmacol Ther. 2018 Mar; 47(6):753-762.
-
Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon. Clin Gastroenterol Hepatol. 2018 Jan; 16(1):68-74.
-
Risk of colorectal cancer in chronic liver diseases: a systematic review and meta-analysis. Gastrointest Endosc. 2017 Jul; 86(1):93-104.e5.
-
Liver Transplantation for Hepatocellular Carcinoma in Young Adults: A United Network for Organ Sharing Study. J Adolesc Young Adult Oncol. 2017 Jun; 6(2):286-293.